Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP490573.RAcTap8zIW6ijKcEPlcsHeCxX6fMGHL4bSupLrwFD521U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP490573.RAcTap8zIW6ijKcEPlcsHeCxX6fMGHL4bSupLrwFD521U130_assertion type Assertion NP490573.RAcTap8zIW6ijKcEPlcsHeCxX6fMGHL4bSupLrwFD521U130_head.
- NP490573.RAcTap8zIW6ijKcEPlcsHeCxX6fMGHL4bSupLrwFD521U130_assertion wasGeneratedBy ECO_0000203 NP490573.RAcTap8zIW6ijKcEPlcsHeCxX6fMGHL4bSupLrwFD521U130_provenance.
- NP490573.RAcTap8zIW6ijKcEPlcsHeCxX6fMGHL4bSupLrwFD521U130_assertion wasDerivedFrom befree-20150227 NP490573.RAcTap8zIW6ijKcEPlcsHeCxX6fMGHL4bSupLrwFD521U130_provenance.
- NP490573.RAcTap8zIW6ijKcEPlcsHeCxX6fMGHL4bSupLrwFD521U130_assertion SIO_000772 14872505 NP490573.RAcTap8zIW6ijKcEPlcsHeCxX6fMGHL4bSupLrwFD521U130_provenance.
- NP490573.RAcTap8zIW6ijKcEPlcsHeCxX6fMGHL4bSupLrwFD521U130_assertion evidence source_evidence_literature NP490573.RAcTap8zIW6ijKcEPlcsHeCxX6fMGHL4bSupLrwFD521U130_provenance.
- NP490573.RAcTap8zIW6ijKcEPlcsHeCxX6fMGHL4bSupLrwFD521U130_assertion description "[We reviewed the clinical features of 3 members of a family, all of whom had MWS associated with the NALP3 variant V200M (also designated V198M), and evaluated the response of their inflammatory disease to treatment with the recombinant human IL-1 receptor antagonist anakinra.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP490573.RAcTap8zIW6ijKcEPlcsHeCxX6fMGHL4bSupLrwFD521U130_provenance.